WASHINGTON — U.S. regulators Tuesday approved Eli Lilly and Co.’s new osteoporosis treatment and its new drug for attention deficit hyperactivity disorder. Forteo, a once-a-day injection, is the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results